MuSK myasthenia gravis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a challenging diagnosis and therapeutic approach
- PMID: 37594551
- DOI: 10.1007/s10072-023-07002-5
MuSK myasthenia gravis as a manifestation of immune reconstitution inflammatory syndrome in an HIV-positive patient: a challenging diagnosis and therapeutic approach
References
-
- Evoli A, Antonini G, Antozzi C et al (2019) Italian recommendations for the diagnosis and treatment of myasthenia gravis. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 40:1111–1124. https://doi.org/10.1007/s10072-019-03746-1 - DOI
-
- Lebrun D, Hentzien M, Cuzin L et al (2017) Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort. AIDS Lond Engl 31:2159–2166. https://doi.org/10.1097/QAD.0000000000001603 - DOI
-
- Ragunathan K, Pathak B, Dahal K (2015) MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. J Neurol 262:777–778. https://doi.org/10.1007/s00415-015-7639-1 - DOI - PubMed
-
- Kuntzer T, Carota A, Novy J et al (2011) Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis. Neurology 76:757–758. https://doi.org/10.1212/WNL.0b013e31820d6290 - DOI - PubMed
-
- Heckmann JM, Marais S (2020) Management issues in myasthenia gravis patients living with HIV: a case series and literature review. Front Neurol 11:775. https://doi.org/10.3389/fneur.2020.00775 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
